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Ketamine is a N -methyl-D-aspartate receptor (NMDAR) antagonist that produces rapid
antidepressant responses in individuals withmajor depressive disorder.The antidepressant
action of ketamine has been linked to blocking NMDAR activation at rest, which inhibits
eukaryotic elongation factor 2 kinase leading to desuppression of protein synthesis and
synaptic potentiation in the CA1 region of the hippocampus. Here, we investigated
ketamine mediated antidepressant response and the resulting synaptic potentiation in
juvenile animals. We found that ketamine did not produce an antidepressant response
in juvenile animals in the novelty suppressed feeding or the forced swim test. In addition
ketamine application failed to trigger synaptic potentiation in hippocampal slices obtained
from juvenile animals, unlike its action in slices from adult animals.The inability of ketamine
to trigger an antidepressant response or subsequent synaptic plasticity processes suggests
a developmental component to ketamine mediated antidepressant efﬁcacy.We also show
that the NMDAR antagonist AP5 triggers synaptic potentiation in mature hippocampus
similar to the action of ketamine, demonstrating that global competitive blockade of
NMDARs is sufﬁcient to trigger this effect. These ﬁndings suggest that global blockade
of NMDARs in developmentally mature hippocampal synapses are required for the
antidepressant efﬁcacy of ketamine.
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INTRODUCTION
Major depressive disorder (MDD) is a serious mental condition in
which there is a need for fast acting treatment. Ketamine, a non-
competitiveN-methyl-D-aspartate receptor (NMDAR) antagonist
has been shown to elicit a rapid antidepressant response in patients
with MDD (Berman et al., 2000; Zarate et al., 2006; Price et al.,
2009) and bipolar depression (Diazgranados et al., 2010a; Zarate
et al., 2012). Ketamine has also been reported to have rapid anti-
suicidal effects (Price et al., 2009; DiazGranados et al., 2010b;
Larkin and Beautrais, 2011; Zarate et al., 2012), an area of crit-
ical unmet need. However, ketamine does not present an ideal
proﬁle as an antidepressant due to its potential psychotomimetic
effects as well as abuse potential. Thus, there has been interest in
delineating the cellular mechanisms that underlie ketamine action
to facilitate development of safer compounds with similar robust
and rapid antidepressant effects.
In recent work, the antidepressant effect of ketamine have
been recapitulated in animal models predictive of antidepres-
sant efﬁcacy (Maeng et al., 2008; Li et al., 2010; Autry et al., 2011;
Nosyreva et al., 2013; Gideons et al., 2014), such as the forced
swim test (FST), the novelty suppressed feeding (NSF) test, and
learned helplessness test. In parallel, in hippocampal slices we
have also observed a form of synaptic potentiation elicited after
30-min application of ketamine in the absence of stimulation.
After ketamine application at rest, we stimulated the Schaffer col-
lateral/commissural afferents and recorded postsynaptic responses
from CA1 dendrites. These responses were signiﬁcantly enhanced
after ketamine treatment in adult rats and mice (Autry et al., 2011;
Nosyreva et al., 2013). The behavioral as well as the synaptic
effects of ketamine are dependent on the function of eukary-
otic elongation factor 2 (eEF2) kinase and protein synthesis as
ketamine failed to elicit a behavioral response or potentiation
on the eEF2 kinase null mice as well as after application of pro-
tein translation blocker anisomycin (Autry et al., 2011; Nosyreva
et al., 2013). Although these studies have provided a strong cor-
relation between the synaptic action of ketamine and its rapid
antidepressant effects, they have not yet addressed whether this
effect is dependent on the stage of synapse development. Synaptic
plasticity related processes are age dependent and their proper-
ties vary during synapse development. For instance, NMDAR
only postsynaptically silent synapses are more prevalent dur-
ing earl stages of synapse development (Wu et al., 1996; Hanse
et al., 2013). We therefore examined whether ketamine elicits an
antidepressant response and triggers similar synaptic potentia-
tion in juvenile animals to that previously observed in adults.
In addition, these earlier studies have not addressed whether the
synaptic effect of ketamine and another use-dependent NMDAR
blocker MK-801 could be mimicked by the widely used com-
petitive non-use dependent NMDAR antagonist D-AP5 [D-AP5
(2R)-amino-5-phosphonopentanoate].
In this study, we report that ketamine does not trigger a
behavioral antidepressant response in juvenile animals as it does
in adults. We also ﬁnd that ketamine does not trigger synap-
tic potentiation in juvenile animals, demonstrating that the
antidepressant and synaptic effects of ketamine require the estab-
lishment of mature synaptic contacts. In addition, we show
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that the competitive NMDAR antagonist D-AP5, elicits synaptic
potentiation in developmentally mature slices complementing the
earlier observation that the competitive NMDAR antagonist 3-
[(R)-2-Carboxypiperazin-4-yl]-propyl-1-phosphonic acid (CPP)
triggers a rapid antidepressant response in vivo (Autry et al., 2011).
MATERIALS AND METHODS
ANIMALS
Male C57BL/6 mice from Jackson Labs and male Sprague–Dawley
rats from Charles River were obtained. For the experimental
paradigms, mice were 4 weeks of age and rats were either 2–3
(developmentally immature/juvenile) or 6–8 (developmentally
mature, young adult) weeks of age (McCutcheon and Marinelli,
2009). Animals were maintained on a 12-h light/dark cycle with ad
libitum access to food and water, except when indicated. All exper-
iments were conducted and analyzed blind to treatment group.
Experiments were approved by the Institutional Animal Care and
Use Committee at the UT Southwestern Medical Center.
DRUG TREATMENT
Ketamine (Fort Dodge Animal Health) and D-AP5 [D-(-)-2-
Amino-5-phosphonopentanoic acid] (Abcam Biochemicals) were
prepared fresh in artiﬁcial cerebral spinal ﬂuid (ACSF) and added
to solutions as indicated. D-AP5, the active isomer of AP5,
was used to avoid potential variability associated with a racemic
mixture. The behavioral experiments utilized mice that were
intraperitoneal (i.p.) injected drug tomore closelymimic the route
of administration in humans. For the ﬁeld potentials (FPs) record-
ings, after 20 min of stable baseline, drugs (ketamine, D-AP5)
were applied for 30 min at rest and then one control stimulus
was applied, after which there was no stimulation during a 1 h
washout. Stimulation was resumed for 30 min after washout.
BEHAVIOR
Novelty suppressed feeding
Mice were food deprived 24 h prior to testing. On testing day,
mice were habituated to single housing in fresh home cages for 1 h.
Mice were given an i.p. injection of vehicle (0.9% saline; n = 10) or
ketamine (3 mg/kg; n= 10) and tested 30 min later. Small pieces of
regular chow were placed in the center of a brightly lit open arena
(42 cm × 42 cm). Mice were introduced into a corner of the arena
and allowed to explore for up to 3 min. Latency to bite the food
was recorded in seconds (s). To control for appetite level, mice
were immediately removed from the test arena after consuming
food or at the end of the 3 min trial and placed individually in the
home cage where they were presented with a pre-weighed amount
of chow for 5 min. The food was weighed at the end of the session
and the amount consumed (difference) was recorded in grams (g).
Forced swim test
The same groups of mice were tested in the forced swim apparatus
24 h after vehicle or ketamine administration. Mice were habitu-
ated to the testing room for 1 h. Four liter beakers were ﬁlled with
3 L of water (24◦C; changed between subjects) and a video camera
was placed on the side of the beakers to record the session. Mice
were placed in the water for 6 min. An observer blind to treatment
scored seconds (s) spent immobile during the last 4 min of the
test.
EXTRACELLULAR FIELD POTENTIAL RECORDINGS
Hippocampal slices (400 μm) were prepared from 14 to 21 day
(young) or 6–8 week (adult) old Sprague Dawley rats, as indi-
cated. Animals were anesthetized with isoﬂurane and decapitated
soon after the disappearance of corneal reﬂexes. The brain was
removed, dissected, and then sliced using a vibratome (VT 1000S,
Leica) in ice–cold dissection buffer containing the following (in
mM): 2.6 KCl, 1.25 NaH2PO4, 26 NaHCO3, 0.5 CaCl2, 5 MgCl2,
212 sucrose, and 10 dextrose. Area CA3 was surgically removed
from each slice immediately after sectioning. The slices were
transferred into a reservoir chamber ﬁlled with ACSF contain-
ing the following (in mM): 124 NaCl, 5 KCl, 1.25 NaH2PO4,
26 NaHCO3, 2 CaCl2, 2 MgCl2, and 10 dextrose. Slices were
allowed to recover for 2–3 h at 30◦C. ACSF and dissection buffer
were equilibrated with 95% O2 and 5% CO2. For recording,
slices were transferred to a submerged recording chamber, main-
tained at 30◦C, and perfused continuously with ACSF at a rate of
2–3 ml/min.
Field potentials were recordedwith extracellular recording elec-
trodes (1 M) ﬁlled with ACSF and placed in stratum radiatum of
area CA1. FPs were evoked by monophasic stimulation (duration,
200 μs) of Schaffer collateral/commissural afferents with a con-
centric bipolar tungsten stimulating electrode (Frederick Haer).
Stable baseline responses were collected every 30 s using a stim-
ulation intensity (10–30 μA), yielding 50–60% of the maximal
response. FPs were ﬁltered at 2 kHz and digitized at 10 kHz on
a personal computer using custom software (LabVIEW, National
Instruments). Synaptic strength was measured as the initial slope
(10–40% of the rising phase) of the FP. The group data were ana-
lyzed as follows: (1) the initial slopes of the FP were expressed
as percentages of the preconditioning baseline average; and (2)
the time-matched, normalized data were averaged across experi-
ments and expressed as mean ± SEM. Signiﬁcant differences were
determined by paired t-test, p < 0.05 was considered to represent
signiﬁcant differences.
STATISTICS
For all experiments the data are represented as mean ± SEM.
For the behavioral experiments, two-tailed t-tests were used to
determine signiﬁcance (p<0.05). For the electrophysiology exper-
iments, signiﬁcant differences were determined by paired t-test,
p < 0.05 was considered to represent signiﬁcant differences.
RESULTS
KETAMINE DOES NOT TRIGGER A RAPID ANTIDEPRESSANT RESPONSE
IN JUVENILE ANIMALS
We investigated whether ketamine triggers an antidepressant
response in 4 week old C57BL/6 juvenile mice. The juvenile mice
were treated with 3.0 mg/kg ketamine (i.p.), a dose that triggers a
rapid antidepressant response in young adult (6–8 week old) mice
(Autry et al., 2011; Nosyreva et al., 2013) and examined 30 min
later in the NSF test. We found no difference between the ketamine
and vehicle treated mice in the latency to consume the food pellet
in the juvenile mice suggesting that ketamine did not trigger an
antidepressant response (Figure 1A). There was no difference in
the amount of food consumed between the ketamine and vehicle
treated groups, suggesting that the ﬁndings in the NSF test were
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FIGURE 1 | Continued
FIGURE 1 | Juvenile mice do not respond behaviorally to acute
ketamine treatment. (A) Four week old C57BL/6 male mice administered
vehicle (saline) or ketamine (3 mg/kg) i.p. display similar latency to consume
food in a novel environment. (B) Food consumption over a period of 5 min is
indistinguishable between ketamine or vehicle-treated juveniles. (C)The
same groups of mice tested 24 h after i.p. vehicle or ketamine treatment
show comparable immobility in the forced swim test.
not confounded by hunger (Figure 1B). To further examine the
antidepressant effects of ketamine in juvenile mice, we tested the
mice 24 h after ketamine treatment in the FST. We found that
ketamine did not alter the immobility time in the FST further sug-
gesting that it does not trigger a behavioral antidepressant response
in juvenile mice (Figure 1C).
KETAMINE APPLICATION AT REST DOES NOT ELICIT APPRECIABLE
SYNAPTIC POTENTIATION IN SLICES FROM JUVENILE ANIMALS
We next examined whether ketamine elicits synaptic potentiation
in hippocampal slices of juvenile mice. To study the effect of
ketamine application on synaptic efﬁcacy, we initially recorded
baseline ﬁeld excitatory postsynaptic potentials (fEPSPs) at a
frequency of 0.03 Hz from the CA1 region of a hippocam-
pal slice from 2 to 3 week old animals following extracellular
stimulation of CA3 Schaffer collaterals. In the setting, follow-
ing 30 min long recordings of the baseline synaptic responses,
stimulation was stopped and 20 μM ketamine was applied for
another 30 min. After subsequent wash out of ketamine we
detected only a modest shift in baseline that did not reach signif-
icance (Figure 2). Previous work has shown that this stimulation
paradigm elicits a signiﬁcant potentiation in mature hippocam-
pal slices (Autry et al., 2011; Nosyreva et al., 2013). To conﬁrm
these previous ﬁndings, we applied the same experimental pro-
tocol in developmentally mature hippocampal slices (6–8 weeks
old) and found that ketamine triggered a robust potentiation that
reached 44 ± 0.004% within 1 h after drug removal (Figure 3A).
These data demonstrate that ketamine does not elicit synaptic
potentiation in developmentally immature synaptic contact as it
does in mature synapses demonstrating an age dependence for the
plasticity mediated processes involved in ketamine action.
APPLICATION OF THE COMPETITIVE NMDAR BLOCKER, D-AP5, AT REST
ELICITS SYNAPTIC POTENTIATION IN MATURE SLICES
To determine whether the widely used competitive NMDAR
antagonist, D-AP5, could elicit synaptic potentiation in devel-
opmentally mature hippocampal slices, we applied D-AP5 to
hippocampal slices from 6 to 8 week old animals using the
same protocol in Figures 2 and 3A. Under these conditions, we
detected a robust potentiation (39 ± 0.006%) of synaptic efﬁcacy
following removal of D-AP5 (Figure 3B). This result indicates
that the synaptic effect of ketamine at rest is not speciﬁc to the
use-dependence of ketamine action and solely requires global
suppression of NMDAR function at rest.
DISCUSSION
In this study, we examined the antidepressant action of ketamine
and its impact on synaptic transmission in juvenile animals and
found an absence of the robust effect of ketamine on behavior and
Frontiers in Molecular Neuroscience www.frontiersin.org December 2014 | Volume 7 | Article 94 | 3
Nosyreva et al. Age dependence of rapid antidepressant action
FIGURE 2 | Ketamine application does not induce significant synaptic
strength potentiation in juvenile animals. Field potentials (FPs) were
recorded in control (n = 6) and ketamine-treated (20 μM) slices (n = 11),
from 14-day-old rats. Initial FP slopes are plotted as a function of time
(mean ± SEM).We did not observe signiﬁcant changes of FP slopes
compared to baseline after 90 min with or without application of ketamine
(p = 0.097 and p = 0.24 respectively). Inset, Representative waveforms
from control and ketamine-treated slices recorded at the times indicated by
the numbers on the graph (1, 2).
synaptic plasticity. This ﬁnding suggests that the antidepressant
effects of ketamine strictly require formation of mature synaptic
circuitry. As NMDAR activity can be detected soon after for-
mation of initial synaptic contacts (Wu et al., 1996; Hanse et al.,
2013), we hypothesize that the number and the strength of these
synapses rather than the presence or absence of NMDARs are likely
determinants of this form of synaptic plasticity. Previous studies
have documented a robust increase in the number of synaptic
contacts within the maturational time scale that we examined
here. For instance, within the CA1 region of the hippocam-
pus the rate of spontaneous miniature excitatory postsynaptic
currents (mEPSC’s) increase fourfold over the ﬁrst 2 months
of development, indicating an increase in synaptic connectiv-
ity as well as a potential increase in the rate of spontaneous
release per synapse (Hsia et al., 1998). As the ability of ketamine
to elicit synaptic potentiation depends on its blockade of rest-
ing NMDAR mediated synaptic currents (Nosyreva et al., 2013;
Gideons et al., 2014), the increase in mEPSC frequency during
this developmental window, therefore, may render synaptic efﬁ-
cacy more susceptible to NMDA-mEPSC block. This premise may
suggest the existence of a speciﬁc threshold for mEPSC activity
to exert its effect on homeostatic synaptic plasticity. However, the
developmental timeline for the emergence of the ketamine effect
may also depend on a developmental switch in protein transla-
tion dependence of synaptic plasticity. Indeed, there is evidence
that mGluR mediated long term synaptic depression (mGluR-
LTD) in juvenile animals is independent of protein synthesis.
FIGURE 3 | Application of D-AP5 and ketamine at rest induces
potentiation of AMPAR-mediated evoked neurotransmission. Field
potentials (FPs) were recorded from ketamine and D-AP5 treated slices
from adult animals. Initial FP slopes are plotted as a function of time
(mean ± SEM). (A) Application of ketamine (20 μM) induces signiﬁcant
increase in FP slopes (n = 8, p < 0.05). (B) Application of D-AP5 (20 μM)
induces signiﬁcant increase in FP slopes (n = 9, p < 0.05). Insets (A,B),
Representative waveforms from D-AP5 and ketamine-treated slices
recorded at the times indicated by the numbers on the graph (1, 2).
However, in mature animals the same mGluR activation pro-
tocol elicits LTD in a manner that requires protein translation
and a long-term decrease in AMPA receptor (AMPAR) surface
expression (Nosyreva and Huber, 2005). In addition, it is possi-
ble that changes in NMDAR expression and their contribution
to synaptic efﬁcacy depending on developmental stages could
impact the ﬁndings. However, at the hippocampal synapses in
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question, NMDAR mediated synaptic responses are detectable
even at very early stages of synapse development (Liao et al., 1995;
Choi et al., 2000) suggesting that lack of NMDARs is an unlikely
scenario.
Our results also show that the competitive NMDAR antago-
nist, D-AP5, can elicit robust synaptic potentiation when applied
to developmentally mature hippocampal slices. This ﬁnding cor-
relates with the previously reported effect of another competitive
NMDAR antagonist, CPP, to elicit a rapid antidepressant like
response in mice (Autry et al., 2011). This ﬁnding that D-AP5
could elicit robust synaptic potentiation is important and in
agreement with earlier work in which we could replicate the
potentiation elicited by ketamine using another use dependent
blocker, MK801. This result, while conﬁrming the speciﬁcity of
the effect to the NMDAR function, left open the question of
whether this plasticity required the application of a use depen-
dent blocker rather than global competitive blockade of NMDAR
at the glutamate binding site. Use dependent blockers by their
nature show higher efﬁcacy to block NMDARs that are juxta-
posed to presynaptic terminals with higher release probability
(Hessler et al., 1993; Rosenmund et al., 1993). Therefore, it is pos-
sible that blockade of higher release probability synapses might
be necessary for this effect as a gradual low frequency activa-
tion at the remaining synapses may be permissive. However, our
results demonstrate that global NMDAR blockade can elicit a sig-
niﬁcant potentiation attesting that the functional subdivision of
NMDAR activation patterns does not play a role in the regula-
tion of this potentiation. It is important to indicate that earlier in
vitro experiments have relied on AP-5 treatment to detect a post-
synaptic protein translation and eEF2 kinase dependent scaling
effect (Sutton et al., 2007). This earlier synaptic scaling effect bears
the hallmarks of the potentiation we detect in acute hippocampal
slices.
It would be interesting to know whether AP5 produces an
antidepressant response. However, literature in the ﬁeld has shown
that peripheral administration of AP5 does not cross into the brain
(Tonkiss and Rawlins, 1991; Coleman et al., 2013). Our choice of
AP5 was based on its common use in examining NMDAR antago-
nismand thus addressing thequestionwhether thepotentiationwe
observed previously using non-competitive open channel blockers
ketamine and MK-801 could be triggered by a competitive blocker.
In addition, in lieu of AP5, we have previously shown that a com-
petitive NMDAR antagonist CPP can exert a rapid antidepressant
effect (Autry et al., 2011).
Antidepressants such as selective serotonin reuptake inhibitors
(SSRIs) have no notable clinical effects in healthy subjects. How-
ever, in rodent models antidepressants including SSRIs and
ketamine trigger ‘antidepressant-like’ effects in naïve animals (e.g.,
Lucki et al., 2001; Monteggia et al., 2004; Adachi et al., 2008; Maeng
et al., 2008; Li et al., 2010; Autry et al., 2011; Nosyreva et al., 2013)
as well as stressed animals in behavioral paradigms such as the
FST and NSF tests. However, a recent study (Donahue et al., 2014)
demonstrated that acute low dose of ketamine failed to attenu-
ate chronic social defeat stress suggesting that ketamine action is
not necessarily more valid in tests of chronic stress in elucidat-
ing the mechanism of antidepressant efﬁcacy per se. Therefore,
these data taken together with the fact that ketamine produces an
antidepressant response in naïve adult animals led us to focus our
study on naïve juvenile animals in the FST and NSF test.
Our ﬁndings demonstrating that ketamine does not trig-
ger antidepressant responses or synaptic potentiation in juvenile
animals suggest a developmental component to antidepressant
efﬁcacy. We also show that global blockade of NMDARs in devel-
opmentally mature hippocampal synapses are required for the
antidepressant efﬁcacy of ketamine. While clinical studies of
ketamine’s action as an antidepressant have not been examined
in juvenile patients with MDD, our ﬁndings suggest a potential
limited therapeutic potential for younger patient populations.
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